This is a preview of subscription content, access via your institution.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
2019/2020 US dollars
Abushanab D, et al. Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study. Clinical Therapeutics : 8 Jan 2021. Available from: URL: http://doi.org/10.1016/j.clinthera.2020.12.004
About this article
Cite this article
Oral ibuprofen cost effective in neonates with patent ductus arteriosis. PharmacoEcon Outcomes News 870, 19 (2021). https://doi.org/10.1007/s40274-021-7422-8